Crossref
A serious challenge in fighting the COVID 19 pandemic: SARS CoV 2 vaccines in oncologic patients
Annals of Research in Oncology · 2021
DOI: 10.48286/aro.2021.23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Research in Oncology, 2021. Verfasst von M. Ruella und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ruella, M., & Ghilardi, G. (2021). A serious challenge in fighting the COVID 19 pandemic: SARS CoV 2 vaccines in oncologic patients. Annals of Research in Oncology. https://doi.org/10.48286/aro.2021.23
Vancouver
Ruella M, Ghilardi G. A serious challenge in fighting the COVID 19 pandemic: SARS CoV 2 vaccines in oncologic patients. Annals of Research in Oncology. 2021. doi:10.48286/aro.2021.23
BibTeX
@article{Ruella2021,
author = {Ruella, M. and Ghilardi, G.},
title = {A serious challenge in fighting the COVID 19 pandemic: SARS CoV 2 vaccines in oncologic patients},
journal = {Annals of Research in Oncology},
year = {2021},
doi = {10.48286/aro.2021.23}
}
EUVIMED